Table 1 Resting hormone concentration of subjects before each trial
| Â | FA | LA | FC | LC | ||||
|---|---|---|---|---|---|---|---|---|
Subject | [E] (pg/mL) | [P] (ng/mL) | [E] (pg/mL) | [P] (ng/mL) | [E] (pg/mL) | [P] (ng/mL) | [E] (pg/mL) | [P] (ng/mL) |
1 | 33.4 | 0.2 | 171.4 | 18.9 | 163.7 | 0.3 | 321.3 | 15.7 |
2 | 34.8 | 0.2 | 125.5 | 10.4 | 42.7 | 0.1 | 98.5 | 7.4 |
3 | 30.8 | 0.4 | 94.0 | 6.0 | 39.4 | 0.2 | 68.3 | 5.7 |
4 | 47.3 | 0.1 | 108.9 | 6.4 | 83.8 | 1.4 | 171.0 | 14.9 |
5 | 50.6 | 0.2 | 201.4 | 13.2 | 98.0 | 0.2 | 327.4 | 19.9 |
6 | 201.0 | 0.4 | 151.2 | 25.6 | 44.0 | 0.4 | 102.1 | 9.1 |
mean | 66.3 | 0.3 | 142.1 | 13.4 | 78.6 | 0.4 | 181.4 | 12.1 |
SD | 66.5 | 0.1 | 40.4 | 7.0 | 48.3 | 0.4 | 115.7 | 5.1 |